Business
BioSpectrum Asia
UK transforms mental healthcare with new strategy
Frontline workers, clinicians and mental health experts are being invited to share their views on how to transform mental healthcare for children and adults in England, as the government launches a call for evidence to shape its once-in-a-generation crossgovernment mental health strategy.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Australia Budget 2026-27: Investing in Care, Health and Innovation.
The Australian Federal Budget 2026-27, presented by the Albanese Government, places strong emphasis on healthcare, aged care, T disability services, research, innovation and social equality.
4 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Gavi proposes new incentives for advancing vaccine manufacturing in Africa
With Gavi's African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance has proposed further measures totaling $189 million of additional investment to further aid development of Africa's vaccine manufacturing sector.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
New WHO online course strengthens good practices in clinical trials
High-quality clinical trials are essential for generating reliable evidence to inform health policy, clinical practice and public trust in science.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
World Bank approves $225 M to improve healthcare in Côte d'Ivoire
The World Bank has approved $225 million in financing to help Côte d'Ivoire improve the delivery of quality health, nutrition, and early childhood development services for millions of people, particularly for women, children, and vulnerable households.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Josh Xiao as CSO
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea lays focus on stabilising medical product supply
The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases
Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Academy of Digital Health Sciences launches two new courses in AI
Academy of Digital Health Sciences (ADHS), based in India, has announced the launch of its landmark 'AI for All' Mission, a bold, mission-driven programme designed to democratise artificial intelligence (AI) across global healthcare systems.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
AstraZeneca Korea names Ohad Goldberg as new Country President
AstraZeneca Korea has appointed Ohad Goldberg, former President of AstraZeneca Israel, as its new Country President, effective May 1.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Holista executes binding JV for collagen facility in Australia
Holista Colltech has entered into a binding Joint Venture (JV) agreement with Swang Chai Chuan (SCC) for the funding, development and operation of an ovine nano-collagen production facility in Collie, Western Australia.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Medit establishes global orthodontic business division
Medit Corp., a global leader in digital dentistry solutions, has announced the establishment of its Global Orthodontic Business Division and the acquisition of Progressive Orthodontics, a leading orthodontic education institution headquartered in Aliso Viejo, California, through its US subsidiary, Medit USA Inc.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
GSK enters exclusive collaboration with SBP Group to accelerate hepatitis B treatment in China
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ), to accelerate bepirovirsen in mainland China at launch.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Singapore and China ink MoU for enhancing regulatory collaboration on health products
Singapore's Health Sciences Authority (HSA) and China's National Medical Products Administration (NMPA) have signed a Memorandum of Understanding (MoU) to renew their commitment in health products regulatory collaboration, so as to support faster access to new & innovative health products for patients & healthcare systems in both countries.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
WHO BOOSTS TRIALS TARGETING $144B BY 2030
Since May 2025, the World Health Organization (WHO) has intensified efforts to strengthen global clinical trial ecosystems in response to rising demand for high-quality, equitable, and efficient research systems.
2 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Fosun Pharma and AriBio ink $180 M deal for treatment of Alzheimer's Disease
Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio, a biopharmaceutical company focused on neurodegenerative diseases, have jointly announced the signing of an exclusive global option agreement for the development, registration, manufacturing and commercialisation of AR1001, an innovative drug candidate for the treatment of Alzheimer's disease (AD).
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Kotak Alts invests Rs 200 M in Cellogen Therapeutics
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to growth-stage life sciences and healthcare businesses, has made an investment of Rs 200 million in Indian startup Cellogen Therapeutics, a biotechnology company focused on cell and gene therapies.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
India's new computational tool Renoir uncovers hidden signals in cancer progression
Researchers at the Indian Institute of Technology Kanpur (IIT-K) have developed an advanced computational tool, Renoir, that enables researchers to decode how cells communicate within complex tissues.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
ASCO 2026 Marked a Defining Moment for Asian Oncology Innovation
The 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), a five-day global oncology gathering held in Chicago and online from May 29, to June 2, concluded as a landmark event for Asian biotechnology and pharmaceutical companies.
4 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Japan's GHIT Fund announces investment of $8.5 M in 5 R&D projects
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.37 billion ($8.5 million) in five R&D projects for the development of drugs for malaria and neglected tropical diseases (NTDs).
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea designs AI-based neckband that converts silent speech into voice
Researchers at Pohang University of Science and Technology (POSTECH) in South Korea have developed an innovative silicone neckband capable of converting silent speech into audio through advanced sensor technology and artificial intelligence (AI).
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
CEL-SCI and Amarox plan commercialisation and distribution of Multikine in Saudi Arabia
US-based CEL-SCI Corporation has signed a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialisation of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
METIS TechBio debuts on Hong Kong Stock Exchange
METIS TechBio, a tech-bio startup focused on AI-powered nanodelivery innovation, has successfully listed on the Hong Kong Stock Exchange (HKEX), becoming the world's first publicly listed AI-powered drug delivery company and the first AI-powered large-molecule biopharmaceutical company listed on the Hong Kong market.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Australia eliminates trachoma as public health problem
The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of Indigenous people and in global efforts to combat neglected tropical diseases (NTDs).
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Japan and Singapore deepen collaboration to enhance access to health products
Singapore's Health Sciences Authority (HSA) and Japan's Ministry of Health, Labour and Welfare (MHLW) have signed a Memorandum of Cooperation (MOC) to enhance bilateral cooperation in health products regulation.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
IHH Healthcare and DBS sign SGD 250 M loan.to advance responsible antibiotic use
IHH Healthcare, a leading multinational healthcare network, has secured an SGD 250 million sustainability-linked loan (SLL) from DBS, a leading financial services group in Asia. The facility includes key performance indicators including a key metric promoting responsible antibiotic use across IHH's four hospitals in Singapore: Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
University of Sydney offers Australia's first part-time medical degree
The University of Sydney will offer its medical students the chance to study the Doctor of Medicine degree on a part-time basis, the first university in Australia to do so.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
How Space Medicine Is Rewriting Healthcare
Long considered the stuff of science fiction, space medicine is rapidly becoming a reality.
7 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
Strand Life Sciences launches South Asia's first Olink Explore HT Proteomics Service
India-based Strand Life Sciences, a subsidiary of Reliance Industries Limited, has announced the launch of its advanced proteomics capabilities powered by Olink Explore HT, marking a key milestone in expanding largescale multi-omics research in South Asia.
1 min |
BioSpectrum Asia June 2026
BioSpectrum Asia
ABEC expands Process Sciences Group to strengthen bioprocess optimisation capabilities
ABEC, a global leader in bioprocess engineering solutions, has announced the expansion of its Process Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the bioprocess lifecycle.
1 min |